bims-emyelo Biomed News
on Emergency myelopoiesis
Issue of 2026–11–01
seven papers selected by
Robbin Kramer, Radboudumc



  1. Front Neurol. 2026 ;17 1976078
      Ischemic stroke rapidly mobilizes myeloid cells from anatomically distinct bone-marrow niches, while emerging evidence indicates that severe cerebral injury can also leave a durable imprint on hematopoiesis. These observations have encouraged the use of the term trained immunity in stroke biology, but acute myeloid expansion is not equivalent to innate immune memory. In this Mini review, we distinguish acute myeloid activation, myelopoietic responses consistent with emergency myelopoiesis, and central trained immunity involving hematopoietic stem and progenitor cells (HSPCs). We use an operational four-feature framework-persistence, progenitor involvement, epigenetic or metabolic reprogramming, and functional recall-to grade the strength of current evidence. We consider a sequential transition from emergency myelopoiesis to trained immunity as one testable possibility rather than an established pathway, while allowing for parallel or independent mechanisms. The key unresolved questions are where durable memory is stored, when acute hematopoietic adaptation becomes stabilized, and which outputs are maladaptive versus reparative. Resolving these boundaries is essential before marrow-directed immunomodulation can be translated to patients with ischemic stroke.
    Keywords:  brain-bone marrow axis; emergency myelopoiesis; hematopoietic stem and progenitor cells; ischemic stroke; neuroinflammation; skull bone marrow; trained immunity
    DOI:  https://doi.org/10.3389/fneur.2026.1976078
  2. bioRxiv. 2026 Oct 10. pii: 2026.10.01.755757. [Epub ahead of print]
      The mammalian BRG-/BRM-associated factor (BAF) chromatin remodeling complexes are crucial regulators of hematopoietic stem and progenitor cell (HSPC) fate. Expression of the ncBAF subcomponent, BRD9, is altered in both normal aging and myeloid malignancies. We find that in adult human HSPC, BRD9 regulates the differentiation of myeloid progenitors. Upon degradation of BRD9 in these cells, ncBAF is displaced from the chromatin, leading in turn to enhanced recruitment of cBAF to bona fide CEBPA target sites. With the shift from ncBAF to cBAF, HSPC differentiation results in increased generation of myeloid-derived suppressor cells (MDSC) that secrete elevated levels of IL-8. Soluble factors from these myeloid cells, which have lost BRD9, enhance the stemness of breast cancer cells in vitro. In contrast, bromodomain inhibition of BRD9 results in minimal alterations of ncBAF binding and myeloid differentiation, indicating that BRD9 acts as a barrier to human MDSC differentiation in a bromodomain-independent manner.
    KEY POINTS: BRD9 suppresses the development of myeloid-derived suppressor cells in a bromodomain-independent mannerLoss of BRD9 results in increased cBAF recruitment to CEBPA target sites and enhanced myeloid differentiation.
    DOI:  https://doi.org/10.64898/2026.10.01.755757
  3. Front Immunol. 2026 ;17 1967804
      Sepsis is accompanied by extensive expansion and remodeling of the myeloid compartment, yet a dysfunctional circulating phenotype does not by itself reveal where that dysfunction arose. Immature markers, low-density fractions, HLA-DR-low phenotypes, transcriptional clusters, and direct T-cell suppression describe different biological levels and carry different mechanistic implications. This review examines sepsis-associated myeloid dysfunction as a source-attribution problem across a marrow-to-blood continuum. Clinical-sepsis studies support altered hematopoietic output and lineage-specific maturation, including emergency-granulopoietic programs in circulating hematopoietic stem and progenitor cells, whereas controlled human systemic endotoxemia provides separate cross-compartment evidence of impaired monocyte maturation. In vitro, plasma from patients with sepsis can program healthy human progenitors toward suppressive myeloid states. Conversely, endotoxin tolerance, epigenetic and metabolic remodeling, activation, and degranulation can generate additional dysfunction after marrow egress. Several human observations argue against a unitary maturation-failure model. Mature CD10-positive neutrophils can suppress T-cell proliferation even when immature CD10-negative cells do not; low-density neutrophils encompass mixed maturity and activation states, and immature neutrophils are kinetically distinct from LOX-1-positive polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-like populations. Monocyte HLA-DR provides a further example because it functions as a dynamic immune-state readout rather than a measure of developmental maturity. Accordingly, we distinguish five evidentiary layers - hematopoietic origin, developmental state, molecular state, functional phenotype, and patient-level immune phenotype - and use them to reassess neutrophil, monocyte, and MDSC-like states. Current human evidence supports contributions from developmental remodeling and peripheral reprogramming, but their relative importance within the same lineage and patient remains unresolved. Resolving that question will require paired compartment sampling, serial multi-omics, direct functional validation, and clinically meaningful longitudinal outcomes rather than greater reliance on computational trajectories or marker-defined identities alone.
    Keywords:  hematopoietic stem and progenitor cells; immune reprogramming; immunoparalysis; monocytes; myeloid-derived suppressor cells; myelopoiesis; neutrophils; sepsis
    DOI:  https://doi.org/10.3389/fimmu.2026.1967804
  4. Exp Hematol. 2026 Oct 30. pii: S0301-472X(26)00594-1. [Epub ahead of print] 105961
      Chronic alcohol consumption-mediated immune dysregulation elevates the risk of multiple diseases, yet how these immunological alterations manifest across tissues remains poorly understood. Here, we investigated the impact of chronic alcohol consumption on hematopoiesis and immune homeostasis across the bone marrow (BM), spleen (SP), and peripheral blood (PB) using female C57BL/6 mice fed a Lieber-DeCarli liquid diet with 6% (v/v) ethanol for 6 weeks. Alcohol consumption induced a mild hepatic injury, evidenced by increased liver weight, elevated plasma levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and hepatic steatosis without fibrosis. Immune phenotyping by high-dimensional spectral flow cytometry showed that, in the BM, alcohol expanded myeloid-biased multipotent progenitors 2 and 3 (MPP2 and MPP3), granulocyte-monocyte progenitors (GMPs), and macrophages. Conversely, the SP exhibited reduced abundance and proliferative activity of lineage-negative c-KIT-positive (LK) and megakaryocyte-erythroid progenitor (MEP) populations, resulting in impaired erythropoiesis. Despite these tissue-specific alterations, PB exhibited comparatively subtle and more variable changes than the BM and SP. These findings demonstrate that alcohol-mediated hematopoietic remodeling is tissue-specific and may not be fully captured by PB analyses. They further highlight the potential need for improved tissue-informed biomarkers and diagnostic approaches to detect and monitor alcohol-mediated immune remodeling beyond PB.
    Keywords:  Alcohol consumption; Blood, Spleen; Bone marrow; Hematopoietic stem cells and progenitors (HSPCs); Immune system
    DOI:  https://doi.org/10.1016/j.exphem.2026.105961
  5. bioRxiv. 2026 Sep 04. pii: 2026.09.01.748392. [Epub ahead of print]
      Obesity expands myeloid progenitors, myelopoiesis and increases the production of monocytes. While weight loss (WL) alleviates aspects of this inflammatory dysregulation, it is not known whether GLP-1 receptor agonists or other traditional modalities of WL differentially modify hematopoietic stem/progenitor cells (HSPCs), hematopoiesis, or inflammatory cell production. To test this, we compared the hematopoietic compartment in lean, obese and weight-reduced mice from tirzepatide treatment and caloric restriction (CR) implemented to match the body weight in both groups. At equal WL, we found CR induced multilineage cytopenias, whereas tirzepatide preserved blood lineages while specifically reducing classical Ly6Chi CCR2+ monocytes. To define the mechanisms underlying these changes we performed single-cell mRNA sequencing of bone marrow HSPCs and mature mononuclear blood cells. CR-HSPCs suppressed gene sets associated with nutrient sensing, proliferation and oxidative phosphorylation (OXPHOS) and exhibited lower inferred cell cycle activity, whereas tirzepatide-HSPCs attenuated these changes. Unlike CR, we found that across progressively differentiated cells from HSPCs to mature blood monocytes, tirzepatide increasingly suppressed OXPHOS and simultaneously shifted the maturation spectrum away from classical monocytes. Following six weeks of tirzepatide withdrawal and weight regain, Ly6Chi CCR2+ monocytes rebounded to levels seen in obese mice. These findings suggest that tirzepatide uncouples WL from the broad hematopoietic suppression seen in CR by preserving progenitor activity but selectively remodeling inflammatory/classical monocytes. We demonstrate that WL modality differentially impacts hematopoietic adaptation and provide evidence that classical monocytes are an effector cell through which tirzepatide may dampen obesity-associated inflammation.
    DOI:  https://doi.org/10.64898/2026.09.01.748392
  6. iScience. 2026 Nov 20. 29(11): 117816
      Leishmaniasis lacks an effective vaccine. We developed a live-attenuated Leishmania major Centrin-deficient strain (LmCen -/-) that is safe and protective in murine and canine models through IFN-γ-producing effector T cells. Because persistent low-level infection supports durable immunity, we investigated latent parasites and immune remodeling in the bone marrow. Dual single-cell RNA sequencing detected parasitized bone marrow cells 28 days after intradermal inoculation with either virulent LmWT or attenuated LmCen -/-. Flow cytometry showed increased myelopoiesis following LmCen -/- immunization compared with LmWT infection. Cell-cell communication analysis implicated enhanced granulin-Sort3 signaling as a potential driver of this response. Bone marrow monocytes from LmCen -/--immunized mice efficiently cleared virulent LmWT parasites in co-culture, consistent with the induction of trained innate immunity. These findings identify the bone marrow as an active site of anti-Leishmania immune programming and suggest that LmCen -/- vaccination promotes durable protection through coordinated adaptive and innate mechanisms.
    Keywords:  HSC; bone marrow immunity; leishmania; live attenuated vaccines; persistent infection; scRNA-seq; trained immunity
    DOI:  https://doi.org/10.1016/j.isci.2026.117816
  7. bioRxiv. 2026 Sep 02. pii: 2026.09.01.747091. [Epub ahead of print]
      Aged hematopoietic stem cells (HSCs) exhibit a shift from balanced to myeloid-biased differentiation, resulting in reduced lymphoid output and impaired adaptive immunity. The question of whether this lineage bias is established in a subset of HSCs during early development or primarily emerges with aging warrants further investigation. Here, we investigate whether myeloid-biased HSCs (my-HSCs) are established at the fetal liver stage by specifically examining Neogenin-1 (NEO1), a previously defined marker of my-HSCs. We identify two distinct populations of Hoxb5 + HSCs in the fetal liver: NEO1 + and NEO1, with NEO1 + HSCs exhibiting transcriptional and functional characteristics consistent with my- HSCs. With age, my-HSC-associated transcriptional programs become increasingly reinforced across the Hoxb5 + pHSC compartment, with NEO1 + cells showing early enrichment of this program and both NEO1 + and NEO1 - cells acquiring broader myeloid-biased features in aging. These findings suggest that lineage programming can begin early in development and is further shaped by age-related changes, potentially contributing to the functional decline observed in the aging hematopoietic system.
    DOI:  https://doi.org/10.64898/2026.09.01.747091